logo

For the Inventor, By the Inventor

Minneapolis, MN, United States of America

Marvin B Bacaner

This inventor holds 7 USPTO granted patents. Top assignees: Sysmed, Inc., Other. Active years: 1985-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marvin B Bacaner. Retrieved from https://idiyas.com/inventor/marvin-b-bacaner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 182(Granted Patents)


Company Filing History:

goldMedal1 out of 3 
 
Sysmed, Inc.
 patents
silverMedal6 out of 834,570 
Other
 patents

Years Active: 1985-2005

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6884792 - Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions (2005-04-26),
2. 6482811 - Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions (2002-11-19),
3. 5043576 - Endotracheal tube and mass spectrometer (1991-08-27),
4. 5036106 - Methods for the treatment of disorders of the cardiac vascular system (1991-07-30),
5. 4966141 - Endotracheal tube and mass spectrometer (1990-10-30),
6. 4850371 - Novel endotracheal tube and mass spectrometer (1989-07-25),
7. 4558223 - Electronic x-ray recording (1985-12-10),

Title: Marvin B Bacaner: Innovator in Cardiovascular Pharmaceutical Compositions

Introduction

Marvin B Bacaner is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cardiovascular conditions. With a total of 7 patents to his name, Bacaner has established himself as a key figure in medical innovation.

Latest Patents

Bacaner’s latest patents focus on bretylium compositions and kits designed for preventing and treating cardiovascular conditions. The first patent describes novel pharmaceutical combinations that include bretylium as the active ingredient, along with methods for utilizing these combinations to address cardiovascular issues. The second patent reiterates this focus, emphasizing the innovative use of bretylium in pharmaceutical compositions and kits aimed at improving cardiovascular health.

Career Highlights

Throughout his career, Bacaner has worked with various companies, including Sysmed, Inc. His work has been instrumental in advancing pharmaceutical technologies that address critical health challenges. His dedication to innovation in the medical field has led to the development of effective treatments that benefit patients with cardiovascular conditions.

Collaborations

Bacaner has collaborated with notable professionals in his field, including John H Broadhurst and Maurice M Kreevoy. These collaborations have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Marvin B Bacaner is a distinguished inventor whose work in cardiovascular pharmaceutical compositions has made a significant impact on medical treatments. His innovative approach and dedication to improving health outcomes continue to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…